Revenues in USD of Turnstone Biologics Corp. from Q2 2022 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
Summary
Turnstone Biologics Corp. quarterly/annual Revenues history and growth rate from Q2 2022 to 2023.
  • Turnstone Biologics Corp. Revenues for the quarter ending March 31, 2023 was $19.3M.
  • Turnstone Biologics Corp. annual Revenues for 2023 was $19.3M, a 73.7% decline from 2022.
Revenues, Quarterly (USD)
Revenues, Annual (USD)
Revenues, YoY Annual Growth (%)

Turnstone Biologics Corp. Quarterly Revenues (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 $19.3M Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-13
Q3 2022 $10.2M Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 $41.9M Apr 1, 2022 Jun 30, 2022 10-Q 2023-09-01

Turnstone Biologics Corp. Annual Revenues (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $19.3M -$54M -73.7% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-31
2022 $73.3M Jan 1, 2022 Dec 31, 2022 10-K 2024-03-22
* An asterisk sign (*) next to the value indicates that the value is likely invalid.